Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Wendie A. Berg, Professor of Radiology, School of Medicine, University of Pittsburgh

The FDA's rule change requiring providers to inform women about breast density could lead to a flurry of questions

Breast density is one of the factors that can influence whether people should pursue supplemental screening. andresr/E+ via Getty Images

The U.S. Food and Drug Administration finalized a regulation in early March 2023 that updates mammography reporting requirements. The new regulation goes into effect on Sept. 10, 2024, and will require that all women receive information about breast density following a mammogram. It will also require they be told in their mammogram report that dense breast tissue can mask cancer and make cancer more difficult to detect.

The Conversation asked Dr. Wendie A. Berg, professor of radiology at the University of Pittsburgh School of Medicine, to explain how the rule change could affect screening recommendations as well as the way people interpret their results.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.